3 Pharma Stocks to Make a Portfolio Feel Better

In a speech at the U.S. Department of Health and Human Services (HHS) on Oct. 25, President Trump detailed how he intends to reduce pharmaceutical prices. His administration plans to establish an "international pricing index" that links the price of certain drugs to what other developed nations pay. The drugs under the microscope are only those generally administered in a doctor's office and covered under Part B of the Medicare program. Because pharmacy drugs are exempt from the plan at this stage, the impact on pharmaceutical companies is likely to be minimal. However, investors should keep up to date with further developments relating to the Trump administration's blueprint to lower drug prices, which was released in May.